{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,8]],"date-time":"2026-05-08T17:18:41Z","timestamp":1778260721525,"version":"3.51.4"},"reference-count":44,"publisher":"Oxford University Press (OUP)","issue":"7","license":[{"start":{"date-parts":[[2022,4,26]],"date-time":"2022-04-26T00:00:00Z","timestamp":1650931200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"name":"Telethon Kids Innovation Fund","award":["PoC2019-006"],"award-info":[{"award-number":["PoC2019-006"]}]},{"name":"Australian National Health and Medical Research Council"},{"DOI":"10.13039\/501100000925","name":"NHMRC","doi-asserted-by":"crossref","award":["GNT1159579"],"award-info":[{"award-number":["GNT1159579"]}],"id":[{"id":"10.13039\/501100000925","id-type":"DOI","asserted-by":"crossref"}]},{"DOI":"10.13039\/501100000925","name":"NHMRC","doi-asserted-by":"crossref","award":["GNT1184428"],"award-info":[{"award-number":["GNT1184428"]}],"id":[{"id":"10.13039\/501100000925","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2022,6,29]]},"abstract":"<jats:title>Abstract<\/jats:title>\n               <jats:sec>\n                  <jats:title>Background<\/jats:title>\n                  <jats:p>Acute rheumatic fever (ARF), an autoimmune reaction to Group A Streptococcus (Streptococcus pyogenes; Strep A) infection, can cause rheumatic heart disease (RHD). New formulations of long-acting penicillins are being developed for secondary prophylaxis of ARF and RHD.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Objectives<\/jats:title>\n                  <jats:p>To evaluate the penicillin G concentrations required to suppress growth of Strep A.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Methods<\/jats:title>\n                  <jats:p>Broth microdilution MIC and MBC for Strep A strains M75611024, M1T15448 and M18MGAS8232 were determined. All strains were studied in a hollow fibre model (initial inoculum 4\u2005log10 cfu\/mL). Constant penicillin G concentrations of 0.008, 0.016 and 0.05\u2005mg\/L were examined against all strains, plus 0.012\u2005mg\/L against M18MGAS8232. Viable counts were determined over 144\u2005h. Subsequently, all penicillin G-treated cartridges were emptied, reinoculated with 5\u2005log10 cfu\/mL and counts determined over a further 144\u2005h. Mathematical modelling was performed.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Results<\/jats:title>\n                  <jats:p>MIC and MBC were 0.008\u2005mg\/L for all strains; small subpopulations of M75611024 and M1T15448, but not M18MGAS8232, grew at 1\u00d7 MIC. Following the first inoculation, 0.008\u2005mg\/L achieved limited killing and\/or stasis against M75611024 and M1T15448, with subsequent growth to \u223c6\u2005log10 cfu\/mL. Following both inocula, concentrations \u22650.016\u2005mg\/L suppressed M75611024 and M1T15448 to &amp;lt;1\u2005log10 cfu\/mL from 6\u2005h onwards with eradication. Concentrations \u22650.008\u2005mg\/L suppressed M18MGAS8232 to &amp;lt;1\u2005log10 cfu\/mL from 24\u2005h onwards with eradication after both inoculations. Mathematical modelling well described all strains using a single set of parameter estimates, except for different maximum bacterial concentrations and proportions of bacteria growing at 1\u00d7 MIC.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Conclusions<\/jats:title>\n                  <jats:p>In the absence of validated animal and human challenge models, the study provides guidance on penicillin G target concentrations for development of new penicillin formulations.<\/jats:p>\n               <\/jats:sec>","DOI":"10.1093\/jac\/dkac124","type":"journal-article","created":{"date-parts":[[2022,4,14]],"date-time":"2022-04-14T11:13:13Z","timestamp":1649934793000},"page":"1923-1930","source":"Crossref","is-referenced-by-count":2,"title":["Penicillin G concentrations required for prophylaxis against Group A <i>Streptococcus<\/i> infection evaluated using a hollow fibre model and mathematical modelling"],"prefix":"10.1093","volume":"77","author":[{"given":"Jessica R","family":"Tait","sequence":"first","affiliation":[{"name":"Drug Delivery, Disposition and Dynamics, Monash Institute of Pharmaceutical Sciences, Monash University , Parkville, Victoria , Australia"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Timothy C","family":"Barnett","sequence":"additional","affiliation":[{"name":"Wesfarmers Centre for Vaccines and Infectious Diseases, Telethon Kids Institute , Perth, Western Australia , Australia"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kate E","family":"Rogers","sequence":"additional","affiliation":[{"name":"Drug Delivery, Disposition and Dynamics, Monash Institute of Pharmaceutical Sciences, Monash University , Parkville, Victoria , Australia"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Wee Leng","family":"Lee","sequence":"additional","affiliation":[{"name":"Drug Delivery, Disposition and Dynamics, Monash Institute of Pharmaceutical Sciences, Monash University , Parkville, Victoria , Australia"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Madhu","family":"Page-Sharp","sequence":"additional","affiliation":[{"name":"Curtin Medical School, Curtin University , Bentley, Western Australia , Australia"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4334-5351","authenticated-orcid":false,"given":"Laurens","family":"Manning","sequence":"additional","affiliation":[{"name":"Wesfarmers Centre for Vaccines and Infectious Diseases, Telethon Kids Institute , Perth, Western Australia , Australia"},{"name":"Faculty of Health and Medical Sciences, University of Western Australia , Perth, Western Australia , Australia"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ben J","family":"Boyd","sequence":"additional","affiliation":[{"name":"Drug Delivery, Disposition and Dynamics, Monash Institute of Pharmaceutical Sciences, Monash University , Parkville, Victoria , Australia"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jonathan R","family":"Carapetis","sequence":"additional","affiliation":[{"name":"Wesfarmers Centre for Vaccines and Infectious Diseases, Telethon Kids Institute , Perth, Western Australia , Australia"},{"name":"Faculty of Health and Medical Sciences, University of Western Australia , Perth, Western Australia , Australia"},{"name":"Department of Infectious Diseases, Perth Children\u2019s Hospital , Perth, Western Australia , Australia"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1492-8590","authenticated-orcid":false,"given":"Roger L","family":"Nation","sequence":"additional","affiliation":[{"name":"Drug Delivery, Disposition and Dynamics, Monash Institute of Pharmaceutical Sciences, Monash University , Parkville, Victoria , Australia"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0928-4743","authenticated-orcid":false,"given":"Cornelia B","family":"Landersdorfer","sequence":"additional","affiliation":[{"name":"Drug Delivery, Disposition and Dynamics, Monash Institute of Pharmaceutical Sciences, Monash University , Parkville, Victoria , Australia"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"286","published-online":{"date-parts":[[2022,4,26]]},"reference":[{"key":"2022070118382483900_dkac124-B1","doi-asserted-by":"crossref","first-page":"953","DOI":"10.1016\/S0140-6736(11)61171-9","article-title":"Rheumatic heart disease","volume":"379","author":"Marijon","year":"2012","journal-title":"Lancet"},{"key":"2022070118382483900_dkac124-B2","doi-asserted-by":"crossref","first-page":"15084","DOI":"10.1038\/nrdp.2015.84","article-title":"Acute rheumatic fever and rheumatic heart disease","volume":"2","author":"Carapetis","year":"2016","journal-title":"Nat Rev Dis Primers"},{"key":"2022070118382483900_dkac124-B3","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1097\/QCO.0b013e3283511d27","article-title":"Streptococcal skin infection and rheumatic heart disease","volume":"25","author":"Parks","year":"2012","journal-title":"Curr Opin Infect Dis"},{"key":"2022070118382483900_dkac124-B4","doi-asserted-by":"crossref","first-page":"713","DOI":"10.1056\/NEJMoa1603693","article-title":"Global, regional, and national burden of rheumatic heart disease, 1990-2015","volume":"377","author":"Watkins","year":"2017","journal-title":"N Engl J Med"},{"key":"2022070118382483900_dkac124-B5","doi-asserted-by":"crossref","first-page":"685","DOI":"10.1016\/S1473-3099(05)70267-X","article-title":"The global burden of group A streptococcal diseases","volume":"5","author":"Carapetis","year":"2005","journal-title":"Lancet Infect Dis"},{"key":"2022070118382483900_dkac124-B6","doi-asserted-by":"crossref","first-page":"2982","DOI":"10.1016\/j.jacc.2020.11.010","article-title":"Global burden of cardiovascular diseases and risk factors, 1990-2019: update from the GBD 2019 study","volume":"76","author":"Roth","year":"2020","journal-title":"J Am Coll Cardiol"},{"key":"2022070118382483900_dkac124-B7","doi-asserted-by":"crossref","first-page":"227","DOI":"10.1016\/j.gheart.2013.08.011","article-title":"Benzathine penicillin G for the management of RHD: concerns about quality and access, and opportunities for intervention and improvement","volume":"8","author":"Wyber","year":"2013","journal-title":"Glob Heart"},{"key":"2022070118382483900_dkac124-B8","volume-title":"2020 Australian Guideline for Prevention, Diagnosis and Management of Acute Rheumatic Fever and Rheumatic Heart Disease (3rd Edition)","author":"RHDAustralia (ARF\/RHD Writing Group)","year":"2020"},{"key":"2022070118382483900_dkac124-B9","doi-asserted-by":"crossref","first-page":"e337\u2013","DOI":"10.1161\/CIR.0000000000000921","article-title":"Contemporary diagnosis and management of rheumatic heart disease: implications for closing the gap: a scientific statement from the American Heart Association","volume":"142","author":"Kumar","year":"2020","journal-title":"Circulation"},{"key":"2022070118382483900_dkac124-B10","doi-asserted-by":"crossref","first-page":"S54","DOI":"10.1016\/j.hlc.2019.05.138","article-title":"Pain in the backside: exploring subcutaneous benzathine penicillin G acceptability","volume":"28","author":"Kado","year":"2019","journal-title":"Heart Lung Circ"},{"key":"2022070118382483900_dkac124-B11","doi-asserted-by":"crossref","first-page":"94","DOI":"10.1097\/CRD.0000000000000065","article-title":"Approaches to improving adherence to secondary prophylaxis for rheumatic fever and rheumatic heart disease: a literature review with a global perspective","volume":"24","author":"Remond","year":"2016","journal-title":"Cardiol Rev"},{"key":"2022070118382483900_dkac124-B12","doi-asserted-by":"crossref","first-page":"729","DOI":"10.1007\/s13346-018-0482-z","article-title":"Lessons learned in the development of sustained release penicillin drug delivery systems for the prophylactic treatment of rheumatic heart disease (RHD)","volume":"8","author":"Montagnat","year":"2018","journal-title":"Drug Deliv Transl Res"},{"key":"2022070118382483900_dkac124-B13","doi-asserted-by":"crossref","first-page":"572","DOI":"10.1007\/s13346-016-0313-z","article-title":"Preliminary consultation on preferred product characteristics of benzathine penicillin G for secondary prophylaxis of rheumatic fever","volume":"6","author":"Wyber","year":"2016","journal-title":"Drug Deliv Transl Res"},{"key":"2022070118382483900_dkac124-B14","doi-asserted-by":"crossref","first-page":"6735","DOI":"10.1128\/AAC.02744-14","article-title":"A population pharmacokinetic modeling approach shows that serum penicillin G concentrations are below inhibitory concentrations by two weeks after benzathine penicillin G injection in the majority of young adults","volume":"58","author":"Neely","year":"2014","journal-title":"Antimicrob Agents Chemother"},{"key":"2022070118382483900_dkac124-B15","doi-asserted-by":"crossref","first-page":"e25308","DOI":"10.1371\/journal.pone.0025308","article-title":"Serum penicillin G levels are lower than expected in adults within two weeks of administration of 1.2 million units","volume":"6","author":"Broderick","year":"2011","journal-title":"PLoS One"},{"key":"2022070118382483900_dkac124-B16","doi-asserted-by":"crossref","first-page":"722","DOI":"10.1097\/INF.0b013e31825051d4","article-title":"Factors associated with loss of penicillin G concentrations in serum after intramuscular benzathine penicillin G injection: a meta-analysis","volume":"31","author":"Broderick","year":"2012","journal-title":"Pediatr Infect Dis J"},{"key":"2022070118382483900_dkac124-B17","doi-asserted-by":"crossref","first-page":"3485","DOI":"10.1016\/j.vaccine.2019.03.059","article-title":"Controlled human infection for vaccination against Streptococcus pyogenes (CHIVAS): establishing a group A Streptococcus pharyngitis human infection study","volume":"37","author":"Osowicki","year":"2019","journal-title":"Vaccine"},{"key":"2022070118382483900_dkac124-B18","doi-asserted-by":"crossref","DOI":"10.1128\/mSphere.00647-18","article-title":"A controlled human infection model of group A Streptococcus pharyngitis: which strain and why?","volume":"4","author":"Osowicki","year":"2019","journal-title":"mSphere"},{"key":"2022070118382483900_dkac124-B19","doi-asserted-by":"crossref","first-page":"398","DOI":"10.1086\/368022","article-title":"Selective modulation of superantigen-induced responses by streptococcal cysteine protease","volume":"187","author":"Kansal","year":"2003","journal-title":"J Infect Dis"},{"key":"2022070118382483900_dkac124-B20","doi-asserted-by":"crossref","first-page":"4668","DOI":"10.1073\/pnas.062526099","article-title":"Genome sequence and comparative microarray analysis of serotype M18 group A Streptococcus strains associated with acute rheumatic fever outbreaks","volume":"99","author":"Smoot","year":"2002","journal-title":"Proc Natl Acad Sci USA"},{"key":"2022070118382483900_dkac124-B21","volume-title":"Performance Standards for Antimicrobial Susceptibility Testing\u2014Thirtieth Edition: M100","author":"CLSI","year":"2020"},{"key":"2022070118382483900_dkac124-B22","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1038\/nprot.2007.521","article-title":"Agar and broth dilution methods to determine the minimal inhibitory concentration (MIC) of antimicrobial substances","volume":"3","author":"Wiegand","year":"2008","journal-title":"Nat Protoc"},{"key":"2022070118382483900_dkac124-B23","doi-asserted-by":"crossref","first-page":"2509","DOI":"10.1093\/jac\/dkw153","article-title":"Effect of different renal function on antibacterial effects of piperacillin against Pseudomonas aeruginosa evaluated via the hollow-fibre infection model and mechanism-based modelling","volume":"71","author":"Bergen","year":"2016","journal-title":"J Antimicrob Chemother"},{"key":"2022070118382483900_dkac124-B24","doi-asserted-by":"crossref","first-page":"1104","DOI":"10.1002\/cpt.2191","article-title":"Evaluation of meropenem-ciprofloxacin combination dosage regimens for the pharmacokinetics of critically ill patients with augmented renal clearance","volume":"109","author":"Agyeman","year":"2021","journal-title":"Clin Pharmacol Ther"},{"key":"2022070118382483900_dkac124-B25","doi-asserted-by":"crossref","first-page":"760255","DOI":"10.3389\/fmicb.2021.760255","article-title":"Antibiotic treatment, mechanisms for failure, and adjunctive therapies for infections by group A Streptococcus","volume":"12","author":"Johnson","year":"2021","journal-title":"Front Microbiol"},{"key":"2022070118382483900_dkac124-B26","doi-asserted-by":"crossref","DOI":"10.1128\/AAC.00252-17","article-title":"Penicillin dried blood spot assay for use in patients receiving intramuscular benzathine penicillin G and Other penicillin preparations to prevent rheumatic fever","volume":"61","author":"Page-Sharp","year":"2017","journal-title":"Antimicrob Agents Chemother"},{"key":"2022070118382483900_dkac124-B27","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1208\/s12248-011-9257-x","article-title":"Development of a new pre- and post-processing tool (SADAPT-TRAN) for nonlinear mixed-effects modeling in S-ADAPT","volume":"13","author":"Bulitta","year":"2011","journal-title":"AAPS J"},{"key":"2022070118382483900_dkac124-B28","doi-asserted-by":"crossref","first-page":"212","DOI":"10.1208\/s12248-011-9258-9","article-title":"Performance and robustness of the Monte Carlo importance sampling algorithm using parallelized S-ADAPT for basic and complex mechanistic models","volume":"13","author":"Bulitta","year":"2011","journal-title":"AAPS J"},{"key":"2022070118382483900_dkac124-B29","doi-asserted-by":"crossref","first-page":"2343","DOI":"10.1128\/AAC.00092-13","article-title":"Quantifying subpopulation synergy for antibiotic combinations via mechanism-based modeling and a sequential dosing design","volume":"57","author":"Landersdorfer","year":"2013","journal-title":"Antimicrob Agents Chemother"},{"key":"2022070118382483900_dkac124-B30","doi-asserted-by":"crossref","first-page":"2252","DOI":"10.1128\/jb.171.4.2252-2257.1989","article-title":"Onset of penicillin-induced bacteriolysis in staphylococci is cell cycle dependent","volume":"171","author":"Maidhof","year":"1989","journal-title":"J Bacteriol"},{"key":"2022070118382483900_dkac124-B31","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1016\/j.jgar.2021.04.021","article-title":"Pharmacodynamics of ceftazidime plus tobramycin combination dosage regimens against hypermutable Pseudomonas aeruginosa isolates at simulated epithelial lining fluid concentrations in a dynamic in vitro infection model","volume":"26","author":"Tait","year":"2021","journal-title":"J Glob Antimicrob Resist"},{"key":"2022070118382483900_dkac124-B32","doi-asserted-by":"crossref","DOI":"10.1128\/AAC.01679-19","article-title":"Meropenem-tobramycin combination regimens combat carbapenem-resistant Pseudomonas aeruginosa in the hollow-fiber infection model simulating augmented renal clearance in critically ill patients","volume":"64","author":"Yadav","year":"2019","journal-title":"Antimicrob Agents Chemother"},{"key":"2022070118382483900_dkac124-B33","doi-asserted-by":"crossref","DOI":"10.1128\/AAC.02055-17","article-title":"Optimization of a meropenem-tobramycin combination dosage regimen against hypermutable and nonhypermutable Pseudomonas aeruginosa via mechanism-based modeling and the hollow-fiber infection model","volume":"62","author":"Landersdorfer","year":"2018","journal-title":"Antimicrob Agents Chemother"},{"key":"2022070118382483900_dkac124-B34","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1086\/514622","article-title":"The pharmacodynamics of \u03b2-lactams","volume":"27","author":"Turnidge","year":"1998","journal-title":"Clin Infect Dis"},{"key":"2022070118382483900_dkac124-B35","doi-asserted-by":"crossref","first-page":"129","DOI":"10.3109\/9781420017137.006","volume-title":"Antimicrobial Pharmacodynamics in Theory and Practice","author":"Tozuka","year":"2007","edition":"2nd edn"},{"key":"2022070118382483900_dkac124-B36","doi-asserted-by":"crossref","first-page":"481","DOI":"10.1056\/NEJM195303192481201","article-title":"\u2018Continuous\u2019 vs. \u2018discontinuous\u2019 therapy with penicillin; the effect of the interval between injections on therapeutic efficacy","volume":"248","author":"Eagle","year":"1953","journal-title":"N Engl J Med"},{"key":"2022070118382483900_dkac124-B37","doi-asserted-by":"crossref","first-page":"831","DOI":"10.1093\/infdis\/158.4.831","article-title":"Correlation of antimicrobial pharmacokinetic parameters with therapeutic efficacy in an animal model","volume":"158","author":"Vogelman","year":"1988","journal-title":"J Infect Dis"},{"key":"2022070118382483900_dkac124-B38","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1126\/science.125.3238.99","article-title":"Mode of action of penicillin","volume":"125","author":"Park","year":"1957","journal-title":"Science"},{"key":"2022070118382483900_dkac124-B39","doi-asserted-by":"crossref","first-page":"128","DOI":"10.1128\/AAC.00604-06","article-title":"Semimechanistic pharmacokinetic\/pharmacodynamic model for assessment of activity of antibacterial agents from time-kill curve experiments","volume":"51","author":"Nielsen","year":"2007","journal-title":"Antimicrob Agents Chemother"},{"key":"2022070118382483900_dkac124-B40","doi-asserted-by":"crossref","first-page":"2137","DOI":"10.1007\/s10096-021-04262-x","article-title":"Revisiting the inoculum effect for Streptococcus pyogenes with a hollow fibre infection model","volume":"40","author":"Marum","year":"2021","journal-title":"Eur J Clin Microbiol Infect Dis"},{"key":"2022070118382483900_dkac124-B41","doi-asserted-by":"crossref","first-page":"166","DOI":"10.1002\/cpt196672166","article-title":"Clinical pharmacology of the new penicillins. 1. The importance of serum protein binding in determining antimicrobial activity and concentration in serum","volume":"7","author":"Kunin","year":"1966","journal-title":"Clin Pharmacol Ther"},{"key":"2022070118382483900_dkac124-B42","doi-asserted-by":"crossref","first-page":"638","DOI":"10.1111\/j.1476-5381.1965.tb01788.x","article-title":"The binding of antibiotics to serum proteins","volume":"25","author":"Rolinson","year":"1965","journal-title":"Br J Pharmacol Chemother"},{"key":"2022070118382483900_dkac124-B43","first-page":"741","article-title":"[The binding of penicillins on the proteins of the blood and tissues]","volume":"12","author":"Scholtan","year":"1962","journal-title":"Arzneimittelforschung"},{"key":"2022070118382483900_dkac124-B44","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1093\/infdis\/133.2.185","article-title":"Binding of antibiotics to the human intracellular erythrocyte proteins hemoglobin and carbonic anhydase","volume":"133","author":"Kornguth","year":"1976","journal-title":"J Infect Dis"}],"container-title":["Journal of Antimicrobial Chemotherapy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/academic.oup.com\/jac\/article-pdf\/77\/7\/1923\/44373662\/dkac124.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/jac\/article-pdf\/77\/7\/1923\/44373662\/dkac124.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,7,1]],"date-time":"2022-07-01T18:40:49Z","timestamp":1656700849000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/jac\/article\/77\/7\/1923\/6573986"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,4,26]]},"references-count":44,"journal-issue":{"issue":"7","published-online":{"date-parts":[[2022,4,26]]},"published-print":{"date-parts":[[2022,6,29]]}},"URL":"https:\/\/doi.org\/10.1093\/jac\/dkac124","relation":{},"ISSN":["0305-7453","1460-2091"],"issn-type":[{"value":"0305-7453","type":"print"},{"value":"1460-2091","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2022,7,1]]},"published":{"date-parts":[[2022,4,26]]}}}